Tumour-specific active enhancers of E and M tumour cells are rich with TF activator protein 1, E26 transformation-specific, transcriptional enhanced associate domain, Runt-related transcription factor, and nuclear factor-κ-light-chain-enhancer of activated B cells (NF-κB) binding sites, indicating that the similar cores of TFs activate chromatin remodeling during EMT [13,58]. Here, NFKB1 is linked to neoplasm.